A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression
Clinical trial NCT01998958 · COMPLETED
Trial details
- NCT number
- NCT01998958
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-27
- Primary completion
- 2015-07-21
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.